Prof. Dr. med. Peter Effert

Bewertungen:
Medizinstudium: An der RWTH Aachen 10/80- 07/86
Staatsexamen
Approbation
1987 Promotion an der RWTH Aachen
Chancen und Folgen der Wiederbelebung im internistischen
Rahmen aus psychiatrischer und psychologischer Sicht" -
Gesamturteil: sehr gut
1988 Amerikanisches Staatsexamen (ECFMG-certification)
Urologische Ausbildung: 1987 Assistenzarzt an der Abteilung für Chirurgie der RWTH Aachen
1988-1989 Assistenzarzt an der Urologischen Klinik der Heinrich-Heine-Universität Düsseldorf
1989-1991 Forschungsstipendium der DFG an der Duke University in Durham und am Lineberger Cancer Research Center der University of North Carolina in Chapel Hill, North Carolina, USA
1991- 1992 Assistenzarzt an der Urologischen Klinik der Heinrich-Heine-Universität Düsseldorf
1992-1996 Assistenzarzt an der Urologischen Klinik der RWTH Aachen, seit 06/95 wissenschaftl. Assistent
04/96-12/96 Oberarzt an der Urologischen Klinik der RWTH Aachen
Wissenschaftliche Tätigkeit: 1989-1991 Forschungsstipendium der DFG an der Duke University in Durham und am Lineberger Cancer Research Center der University of North Carolina in Chapel Hill, North Carolina, USA
Mai 1996 Habilitation
Facharztanerkennung Urologie: 10/1994 Facharztanerkennung Urologie
Praxis: seit dem 01.01.1997 selbständig in eigener urologischer Gemeinschaftspraxis und Belegabteilung
seit 01.04.1999 zusammen mit Dr. Michael Benedic
Mitgliedschaften: DGU - Deutsche Gesellschaft für Urologie
Fellow of the European Board of Urology
Rheinisch-Hanseatischer urologischer Arbeitskreis
Hobbies: Fliegenfischen
Sport: Laufen, Skilaufen, Golf
Sprachen: Englisch, Französisch

 

Prof. Dr. med. Peter Effert

Publikationen

Effert, P., Frye, R., Neubauer, A., Liu, E., Walther, P.: Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: Analysis of archival human prostate cancer specimens by differential polymerase chain reaction. J. Urol., 147: 192-196, 1992.

Effert, P., Neubauer, A., Walther, P., Liu, E.: Alterations of the p53 gene are involved in the progression of a human prostate carcinoma. J. Urol., 147: 789-793, 1992.

Neubauer, A., Neubauer, B., He, M., Effert, P., Iglehart, D., Frye, R., Liu, E.: Technical report: Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene, 7: 1019-1025, 1992.

Wiener, J., Effert, P., Humphrey, P., Liu, E., Walther, P.: Prevalence of human papillomavirus types 16 and 18 in squamous cell carcinoma of the penis: A retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int. J. Cancer, 50: 694-701, 1992.

Effert, P., Liu, E., Raab-Traub, N.: Alterations of the p53 gene in nasopharyngeal carcinoma. J. Virol., 66, 3768-3775, 1992.

Levendakou, E., Strohmeyer, T., Effert, P., Walther, P., Liu, E.: Expression of the Matrix-GIa protein in urogenital malignancies. Int. J. Cancer, 52, 534-537, 1992.

Effert, P., Ackermann, R.: Clinical manifestation and indication for therapy in benign prostatic hyperplasia. Urologe A, 31, 135-141, 1992.

Effert, P., McCoy, R., Walther, P., Liu, E.: P53 gene alterations in human prostate carcinoma. J. Urol., 150, 257-261, 1993.

Strohmeyer, T., Effert, P.: Das Prostatakarzinom: Zytogenetische und molekularbiologische Grundlagen. Med. Klinik, 88, 482-484, 1993.

Boeckmann, W., Effert, P., Wolff, J.M., Jakse, G.: Laparoscopic pelvic lymphadenectomy. Acta Urol Belg 62: 45-50, 1994.

Effert, P., Strohmeyer, T.: Basic research in prostate cancer: Molecular Biology. Acta Urol Belg 62: 15-21, 1994.

Wolff, J.M., Boeckmann, W., Effert, P., Handt, S., Jakse, G.: Evaluation of patients with diseases of the prostate using prostate-specific antigen density. Br. J. Urol.: 76, 41-46, 1995.

Effert, P., Strohmeyer, T.: Theories on the metastatic process and possible therapeutic options. Urol. Res. 23: 11-19, 1995.

Effert, P., Wendt, G., Handt, S., Wolff, J.M., Keulers, R., Jakse, G.: Direct invasion of the renal vein by metastatic testicular cancer. Europ. Urol. 31(1): 119-121, 1997

Effert, P., Gastl, G., Strohmeyer, G.: Current and future strategies to block tumor angiogenesis, invasion and metastasis. World J. Urol.14: 131-140, 1996.

Effert, P., Bares, R., Handt, S., Wolff, J., Büll, U., Jakse, G.: Metabolic imaging of untreated prostate cancer by positron emission tomography with fluorine-18-labeled deoxyglucose (FDG-PET). J. Urol. 155(3): 994-998, 1996.

Boeckmann, W., Wolff, J., Adam, G., Effert, P., Jakse, G.: Laparoscopic bilateral ureterolysis in Ormond`s disease. Urol Int 56: 133-136, 1996.

Wolff, J., Borchers, H., Effert, P., Habib, F., Jakse, G.: Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. Br. J. Urol. 78: 409-413, 1996.

Effert, P., Boeckmann, W., Wolff, J., Jakse, G.: Laparoscopic pelvic lymphadenectomy in prostate cancer: results in 120 patients. Urologe A 35: 413-417, 1996.

Planz, B., Striepecke, E., Wolf J.M., Effert, P., Jakse, G., Boecking A.: DANA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas. Gen. Diagn. Pathol. 142(2): 69-73, 1996.

Wolff, J., Boeckmann, W., Effert, P., Handt, S., Jakse, G.: Clinical use of prostatespecific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostate. Eur Urol 30(4): 451-457, 1996

Schorn, H., Boeckmann, W., Wolff, J.M., Effert, P., Jakse, G.: Genital self-mutilation: sub-preputial space- the final frontier? Br. J. Urol.: 78(6):949-950, 1996.

Wolff, J.M., Boeckmann, W., Effert, P., Habib, F.K., Jakse, G.: Increased discrimination between benign prostatic hyperplasia and prostate cancer through measurement of percentage free PSA. Anticancer Res. 17(4B): 2993-2994, 1997

Cremerius U., Effert, P., Adam, G., Sabri, O., Zimmy, M., Wagenknecht, G., Jakse, G., Buell, U.: FDG PET for detection and therapy control of metastatic germ cell tumor. J. Nucl. Med.: 39(5): 815-822, 1998.

Fuzesi, L., Gunawan, B., Braun, S., Bergmann, F., Brauers, A., Effert, P., Mittermayer, C.: Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly. Cancer Genet Cytogenet 107(1): 1-6, 1998.

Effert, P.: Notfälle in der Urologie. Medizin im Bild 2: 14-17, 1998.

Effert, P., Röttger, P., Steffens, J.: Das zystische Nephrom. Urologe B 39: 499-501, 1999.

Thiel, R., Effert, P.: Primary adenocarcinoma of the seminal vesicles. J. Urol. 168: 1891-1896, 2002.

Seifert, P., Benedic, M., Effert, P.: Nerve fibers in tumors of the human urinary bladder. Virchows Arch (Germany) 440(3): 291-297, 2002.

Effert, P., Hillger, H.: Gute Erfahrungen mit Estramustinphosphat in der Second-line-Therapie. Uro News 1: 1- 3, 2003

Effert, P., Seifert, P.: Invasive poten tial of „noninvasive“ human bladder carcinoma: An electron microscopy study. Am J Clin Pathol 120: 188-193, 2003

Thiel, R., Effert, P., Konrad, G.: Primäres Samenblasenkarzinom- Was muss der Urologe wissen? Extracta urologica 10: 15-17, 2003

Strohmeyer D., Peschel R., Effert, P., Borchert, O., Janetschek, G., Bartsch, G., Frauscher, F.: Changes of renal blood flow in nephroptosis: Assessment by color doppler imaging, isotope renography and correlation with clinical outcome after laparoscopic nephropexy. Eur Urol, accepted for publication

Vögeli, T., Kurz, A., Grimm, O., Effert, P., Eckardt K.: Anemia under androgen deprivation: Influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system. Europ Urol – submitted for publication

Strohmeyer, D., Strauß, F., Rössing, Ch., Roberts, Ch., Kaufman, O., Bartsch, G., Effert, P.: Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma. Anticancer Res – submitted for publication